These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4379968)

  • 41. [Determination of the effect of the short-term administration of Pondex, methylphenidate, and placebo by various pshychological tests].
    Sindelárová M; Bojanovský J
    Act Nerv Super (Praha); 1967 Nov; 9(4):374. PubMed ID: 4388630
    [No Abstract]   [Full Text] [Related]  

  • 42. A preliminary evaluation of magnesium pemoline in chronic schizophrenic patients.
    Bishop MP; Gallant DM; Thompson RD
    Am J Psychiatry; 1968 Jan; 124(7):982-6. PubMed ID: 4383523
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of effect of pemoline on the incorporation of [3H] uridine into RNA in brain slices.
    Cain DF
    Life Sci; 1967 Sep; 6(18):1919-26. PubMed ID: 6052686
    [No Abstract]   [Full Text] [Related]  

  • 44. Hippocampal injections of magnesium pemoline and the extinction of a bar press response in rats.
    Hepburn E; Saunders JC
    Psychopharmacologia; 1972; 27(2):157-62. PubMed ID: 4638210
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of the clinical effect of short-term administration of Pondex, methylphenidate, and placebos in neuroses].
    Bojanovský J; Hánysová Z; Bouchal M; Náhunek K; Vanýsek J
    Act Nerv Super (Praha); 1967 Nov; 9(4):373. PubMed ID: 4388629
    [No Abstract]   [Full Text] [Related]  

  • 46. Magnesium pemoline and human performance.
    Cameron DE
    Science; 1967 Aug; 157(3791):958-9. PubMed ID: 5212410
    [No Abstract]   [Full Text] [Related]  

  • 47. [On some pharmacologic properties of 5-phenyl-2-cyclopropylamino-4-oxazolinone (LD 3695)].
    Giudicelli R; Najer H; Prouteau M; Sarret M
    C R Acad Hebd Seances Acad Sci D; 1966 Jan; 262(1):213-6. PubMed ID: 4379379
    [No Abstract]   [Full Text] [Related]  

  • 48. [Analeptic action of N,N,N-trimethyl-2(3-benzisoxazolyloxy)ethylammonium iodide].
    Piccinin GL; Mantovani P; Bertaccini G; Vitali T
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1104-8. PubMed ID: 4392981
    [No Abstract]   [Full Text] [Related]  

  • 49. THE TRIAL OF A NEW STIMULANT, PEMOLINE, IN THE TREATMENT OF FATIGUE IN STUDENTS.
    LUCAS CJ; KNOWLES JB
    J Am Coll Health Assoc; 1963 Dec; 12():187-94. PubMed ID: 14134049
    [No Abstract]   [Full Text] [Related]  

  • 50. Action of pemoline on RNA metabolism in the brain.
    Puig Muset P; Ramia J; Martín-Esteve J
    Nature; 1967 Jul; 215(5100):522-3. PubMed ID: 6057918
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of PMH (1) and pemoline activity after electroconvulsive shock.
    Plotnikoff N
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):175-85. PubMed ID: 5465078
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of phenoxazole on memory].
    Algodoal FC
    Hospital (Rio J); 1967 Nov; 72(5):1451-4. PubMed ID: 5307818
    [No Abstract]   [Full Text] [Related]  

  • 53. [Psychotropic drugs in the contemporary psychiatric treatment].
    Brzezicki E
    Neurol Neurochir Psychiatr Pol; 1965; 15(4):565-71. PubMed ID: 4378896
    [No Abstract]   [Full Text] [Related]  

  • 54. Medication for attention deficit hyperactivity disorder: commentary and response.
    Faigel HC; Heiligenstein E
    J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
    [No Abstract]   [Full Text] [Related]  

  • 55. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of magnesium pemoline upon acquired DRL performance.
    Thompson RW; Meyer ME
    Psychol Rep; 1969 Apr; 24(2):425-6. PubMed ID: 5809035
    [No Abstract]   [Full Text] [Related]  

  • 57. Some pharmacologic properties of thozalinone, a new excitant.
    Greenblatt EN; Osterberg AC
    Toxicol Appl Pharmacol; 1965 Jul; 7(4):566-78. PubMed ID: 4378772
    [No Abstract]   [Full Text] [Related]  

  • 58. Self-injurious behavior vs. nonsuicidal self-injury: the CNS stimulant pemoline as a model of self-destructive behavior.
    Bloom CM; Holly S; Miller AM
    Crisis; 2012 Jan; 33(2):106-12. PubMed ID: 22343062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of Pondex, methylphenidate and placebo during short term administration and the effect on serum potassium, calcium and sodium levels in neurotic patients].
    Bojanovský J; Hánysová Z
    Act Nerv Super (Praha); 1967 Nov; 9(4):375-6. PubMed ID: 4388631
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of psychotropic drugs on the fatigue states based on psychological tests].
    Chojnowski JR; Zydowicz L; Chojnowska-Jezierska J; Adamska-Dyniewska H
    Wiad Lek; 1970 Sep; 23(18):1619-23. PubMed ID: 4394292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.